Qiagen N.v. · NYSE:QGEN

Qiagen — Investor Presentation (June 2026)

4 slides from Qiagen's investor presentation, Jun 11, 2026

Slide 1: Accelerating Access to Targeted Therapies
ACCELERATING ACCESS TO TARGETED THERAPIES Pharma companies Drug development focus Need diagnostic partners for assay development and validation Require scalable solutions for commercialization Is the patient eligible for a Trusted partner specific Proven diagnostic expertise treatment? ✓ Companion d
Slide 2: Companion Diagnostics Across the Full Workflow
COMPANION DIAGNOSTICS ACROSS THE FULL WORKFLOW Unique companion diagnostic offering Driving the next wave of growth Sample QIAsymphony 3 Pharma partnerships technologies QIAcube EZ2 with QIAcuityDx digital PCR Detection NGS QIAcuity dPCR >30 Master collaboration QIAstat-Dx agreements Analysis QDI 15
Slide 3: Beyond a Single Test: Driving Long-Term Growth
BEYOND A SINGLE TEST: DRIVING LONG-TERM GROWTH Value creation Why we are positioned to win For our partner Expand the content portfolio (new assays, biomarkers and applications) Enabling better Partnerships provide early treatment decisions Increase instrument clinical insights placements For our pa
Slide 4: Case study: Breast cancer patient journey
Case study: Breast cancer Breast cancer patient journey: From diagnosis to treatment decision >2 mn Companion diagnostics Supporting timely and informed treatment decisions New breast cancer cases annually worldwide Additional companion diagnostic testing Diagnosis Need for rapid and reliable testin